Showing results (1631-1640 of 5,535) with videos related to

Sort By:
Pageof 554
Inflammatory Bowel Diseases|July 30, 2009
Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseC Reiff, M Delday, G Rucklidge, et al.
Inflammatory Bowel Diseases|August 29, 2009
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancerStephan Brackmann, Geir Aamodt, Solveig Norheim Andersen, et al.
Inflammatory Bowel Diseases|August 29, 2009
A new tool to measure the burden of Crohn's disease and its treatment: do patient and physician perceptions match?Allison R Wilcox, Maria Concepcion C Dragnev, Christopher J Darcey, et al.
Inflammatory Bowel Diseases|August 29, 2009
Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependentAlip Borthakur, Sumit Bhattacharyya, Waddah A Alrefai, et al.
Inflammatory Bowel Diseases|August 29, 2009
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitisDaniel C Baumgart, Stephan R Targan, Axel U Dignass, et al.
Inflammatory Bowel Diseases|August 29, 2009
Course of inflammatory bowel disease in patients infected with human immunodeficiency virusNikos Viazis, John Vlachogiannakos, Ourania Georgiou, et al.
Inflammatory Bowel Diseases|August 26, 2009
Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitisLiliana Andrade Chebli, Leonardo Duque de Miranda Chaves, Felipe Ferreira Pimentel, et al.
Inflammatory Bowel Diseases|July 4, 2009
Factors predicting the outcome of disease activity assessment in Crohn's diseaseHenrik Stjernman, Curt Tysk, Sven Almer, et al.
Inflammatory Bowel Diseases|August 18, 2009
Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitisClaudia Huebner, Brian L Browning, Ivonne Petermann, et al.
Inflammatory Bowel Diseases|July 3, 2009
Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium-induced colitisTsukasa Ishida, Masaru Yoshida, Makoto Arita, et al.
Pageof 554